Eli Lilly Halts Work on Heart Drug After Poor Performance in Clinical Trial
Drug maker Eli Lilly & Co. announced on Monday that it had halted work on an experimental heart drug, after the drug, evacetrapib, failed to perform well in a clinical [...]